NDC 43068-304

Hetlioz LQ

Tasimelteon

Hetlioz LQ is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is Tasimelteon.

• Product ID: 43068-304_3248eef5-6bad-4844-a6f9-2f5fddd39c8d
• NDC: 43068-304
• Product Type: Human Prescription Drug
• Proprietary Name: Hetlioz LQ
• Generic Name: Tasimelteon
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2020-12-10
• Marketing Category: NDA / NDA
• Application Number: NDA214517
• Labeler Name: Vanda Pharmaceuticals Inc.
• Substance Name: TASIMELTEON
• Active Ingredient Strength: 4 mg/mL
• Pharm Classes: Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 43068-304-02

1 BOTTLE in 1 CARTON (43068-304-02) > 48 mL in 1 BOTTLE

• Marketing Start Date: 2020-12-10
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Hetlioz LQ" or generic name "Tasimelteon"

NDC	Brand Name	Generic Name
43068-220	Hetlioz	tasimelteon
43068-304	Hetlioz	tasimelteon
0480-4490	Tasimelteon	Tasimelteon